Viewing Study NCT06986057


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-02-23 @ 4:28 AM
Study NCT ID: NCT06986057
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-22
First Post: 2025-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer
Sponsor: Shandong Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module